These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26995994)

  • 1. [Colorectal cancer screening based on quantitative determining of fecal hemoglobin and transferrin].
    Filimonov AV; Kotlyarov EV; Bilan EV
    Vopr Onkol; 2015; 61(6):994-7. PubMed ID: 26995994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.
    Gies A; Cuk K; Schrotz-King P; Brenner H
    Clin Transl Gastroenterol; 2018 Jul; 9(7):168. PubMed ID: 29976921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.
    Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Fann JC; Chou CK; Lee YC; Wu MS; Chen HH
    Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.
    van Rossum LG; van Rijn AF; van Oijen MG; Fockens P; Laheij RJ; Verbeek AL; Jansen JB; Dekker E
    Int J Cancer; 2009 Aug; 125(4):746-50. PubMed ID: 19408302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
    Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are hemoglobin levels really lower in faecal immunochemical test positive patients with colorectal cancer?
    Ng JY; Tan IJ; Tan KK
    Surgeon; 2018 Feb; 16(1):36-39. PubMed ID: 28108269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia.
    Lane JM; Chow E; Young GP; Good N; Smith A; Bull J; Sandford J; Morcom J; Bampton PA; Cole SR
    Gastroenterology; 2010 Dec; 139(6):1918-26. PubMed ID: 20723544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests.
    Gies A; Gruner LF; Schrotz-King P; Brenner H
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1829-1839.e4. PubMed ID: 30851476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests.
    Miyoshi H; Ohshiba S; Asada S; Hirata I; Uchida K
    Am J Gastroenterol; 1992 Jan; 87(1):67-73. PubMed ID: 1728128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
    Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
    Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Temperature and Time on Fecal Hemoglobin Stability in 5 Fecal Immunochemical Test Methods and One Guaiac Method.
    Catomeris P; Baxter NN; Boss SC; Paszat LF; Rabeneck L; Randell E; Serenity ML; Sutradhar R; Tinmouth J
    Arch Pathol Lab Med; 2018 Jan; 142(1):75-82. PubMed ID: 28967803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the severity of colorectal lesion by fecal hemoglobin concentration observed during previous test in the French screening program.
    Balamou C; Koïvogui A; Rodrigue CM; Clerc A; Piccotti C; Deloraine A; Exbrayat C
    World J Gastroenterol; 2021 Aug; 27(31):5272-5287. PubMed ID: 34497450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.